Curcumin Improves Diabetic Cardiomyopathy by Inhibiting Pyroptosis through AKT/Nrf2/ARE Pathway
Mediators of Inflammation · 17.04.2023 · 2023 · 1-20
DOI: 10.1155/2023/3906043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, erschienen am 17.04.2023. Verfasst von Zhang Wei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine of The First Affiliated Hospital of Bengbu Medical College, Bengbu City, Anhui, China 233000. Hauptthemen laut MEDLINE: Curcumin, Diabetic Cardiomyopathies, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Science and Technology Projects in Anhui Province.
Abstract (Originalsprache)
This study is aimed at exploring whether curcumin can regulate the AKT pathway, promote the transfer of Nrf2 into the nucleus, and inhibit cell pyroptosis in diabetic cardiomyopathy. Diabetic rats and cardiomyocytes were treated with curcumin to study its effect on myocardial pyroptosis. Whether curcumin can promote the transfer of Nrf2 into the nucleus through AKT pathway regulation was assessed by western blotting and immunofluorescence. The Nrf2 knockout vector and ml385 were used to block the Nrf2 pathway, and the differences between the different groups in the expression of pyroptosis protein, cell activity, and incidence of apoptosis were evaluated to verify the relationship between the effect of curcumin on pyroptosis inhibition and the Nrf2 pathway. Curcumin promoted the transfer of Nrf2 into the nucleus through the AKT pathway and increased the expression of the antioxidant factors HO-1 and GCLC. These effects reduced reactive oxygen species accumulation and mitochondrial damage in diabetic myocardium and inhibited diabetes-induced pyroptosis. However, in cardiomyocytes with a blocked Nrf2 pathway, the ability of curcumin to inhibit pyroptosis was significantly reduced, and the protective effect on the cells was lost. Curcumin can reduce the accumulation of superoxide in the myocardium through AKT/Nrf2/ARE pathway activation and inhibit pyroptosis. It also has a role in diabetic cardiomyopathy treatment. This study provides new directions for evaluating the mechanism of diabetic cardiomyopathy and treating diabetic myocardium.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine of The First Affiliated Hospital of Bengbu Medical College, Bengbu City, Anhui, China 233000.
- Department of Cardiac Surgery of The First Affiliated Hospital of Bengbu Medical College, Bengbu City, Anhui, China 233000.
ORCID-Profile: Zhang Wei, Qian Shaohuan, Shi Chao
Förderung
- Major Science and Technology Projects in Anhui Province
Zitieren
APA
Wei, Z., Pinfang, K., Jing, Z., Zhuoya, Y., Shaohuan, Q., & Chao, S. (2023). Curcumin Improves Diabetic Cardiomyopathy by Inhibiting Pyroptosis through AKT/Nrf2/ARE Pathway. Mediators of Inflammation, 2023, 1-20. https://doi.org/10.1155/2023/3906043
Vancouver
Wei Z, Pinfang K, Jing Z, Zhuoya Y, Shaohuan Q, Chao S. Curcumin Improves Diabetic Cardiomyopathy by Inhibiting Pyroptosis through AKT/Nrf2/ARE Pathway. Mediators of Inflammation. 2023;2023:1-20. doi:10.1155/2023/3906043
BibTeX
@article{Wei2023,
author = {Wei, Zhang and Pinfang, Kang and Jing, Zhou and Zhuoya, Yao and Shaohuan, Qian and Chao, Shi},
title = {Curcumin Improves Diabetic Cardiomyopathy by Inhibiting Pyroptosis through AKT/Nrf2/ARE Pathway},
journal = {Mediators of Inflammation},
year = {2023},
volume = {2023},
pages = {1--20},
doi = {10.1155/2023/3906043}
}
EUVIMED